
11.69 Delayed Data As of May 24 | ![]() Today’s Change | 5.06 Today|||52-Week Range 14.34 | +79.57% Year-to-Date |
Wall Street Analysts Predict a 34% Upside in Evolus, Inc. (EOLS): Here's What You Should Know May 23 / Zacks.com - Paid Partner Content | Has Evolus (EOLS) Outpaced Other Medical Stocks This Year? May 23 / Zacks.com - Paid Partner Content |
Previous close | 11.65 |
Today’s open | 11.81 |
Day’s range | 11.65 - 11.87 |
Volume | 21,818 |
Average volume (3 months) | 525,948 |
Market cap | $679.9M |
Earnings growth (last year) | +80.54% |
Earnings growth (this year) | +7.48% |
Earnings growth (next 5 years) | +16.00% |
Revenue growth (last year) | +76.29% |
P/E ratio | NM |
Price/Sales | 3.25 |
Price/Book | 8.23 |
Next reporting date | August 4, 2022 |
EPS forecast (this quarter) | -$0.26 |
Annual revenue (last year) | $99.7M |
Annual profit (last year) | -$46.8M |
Net profit margin | -46.96% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newport Beach, California |